The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,637.00
Bid: 1,636.50
Ask: 1,637.50
Change: -13.50 (-0.82%)
Spread: 1.00 (0.061%)
Open: 1,650.50
High: 1,658.50
Low: 1,637.00
Prev. Close: 1,650.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: GSK, Sainsbury's, BT, Imagination Technologies

Sun, 21st Feb 2016 17:23

(ShareCast News) - Financial institutions in the City of London are fairly pleased with David Cameron's agreement with the European Union ahead of June's referendum as it looks to have secured the Square Mile from excessive further Brussels red tape. A potentially painful sticking point has been avoided as financial freedoms are covered in the first section of the agreement, the Sunday Times said, with countries outside the eurozone have been given the right to determine how their banks and other big institutions are regulated.Sainsbury's bid for Argos owner Home Retail Group has been thrown into turmoil by a last-minute £1.4bn bid by South Africa's Steinhoff International. Steinhoff, which is 17% owned by billionaire Iceland and New Look owner Christo Wiese, has approached HRG with a cash offer believed to be worth 175p a share, the Mail on Sunday reported, which is above Sainsbury's 160p mixture of cash and shares that was due to be formalised on Tuesday evening.The Sunday Times reported that Sainsbury's could seek an extension to the deadline as it battles Steinhoff, which owns Bensons for Beds and Harveys in Britain, though the value of the supermarket group's bid has risen to 167p as its shares have appreciated. Bernstein analyst Bruno Monteyne said he expected Sainsbury's to match the Steinhoff bid.Revenues from GlaxoSmithKline's biggest-selling drug, asthma treatment Advair, will be devastated by two rival, generic treatments in development by its rivals. Competitor Mylan has now submitted an application for its US Food and Drug Administration, the Sunday Times reported, with the regulator able to approve the drug early next year.BT will not be forced by regulator Ofcom to sell its Openreach infrastructure arm, the Mail on Sunday said. But the telecoms giant is expected to propose a greater separation of Openreach from the rest of the company, including the possibility of a separate board and a new corporate structure for Openreach or more rules to reduce the influence of BT group management over its strategy.Smartphone chip designer Imagination Technologies has held talks with potential US suitor Rambus about a potential £850m bid. The Nasdaq-listed company was rejected when it made an informal bid last year, inside sources told the Sunday Times. The auction for a majority stake of National Grid's £11bn gas pipeline arm is set to kick off in late spring, with jostling suitors including a group made up of Canada's Borealis Infrastructure, Wren House, a division of Kuwait's sovereign wealth fund, and the Universities Superannuation Scheme.Banks remain concerned that one their most popular means of raising money, via the contingent convertible or CoCo bond market, has dried up. European lenders had planned to issue €40bn of bonds this year, the Sunday Telegraph reported, but the dive in CoCo prices and only partial rebound has seen no issuances in 2016, leaving a big question market over the industry.Taxpayer owned banks Royal Bank of Scotland and Lloyds Banking Group are both expected to unveil combined closures of more than 400 bank branches this week alongside their results. Squashed by low interest rates and high bills for PPI misselling, the pair are forecast to announce tougher cost cutting in coming years, the Sunday Telegraph said, with only political pressures preventing much larger cuts.The two banks' results will see around £10bn paid out in dividends and bonuses, the Mail on Sunday said. This would result in Lloyds paying the treasury £180m from its 9% stake, while an RBS' dividend is still being withheld.Permission needs to be gained from the Bank of England, with Lloyds chief executive Antonio Horta-Osorio aiming to pay about £1.5bn, or 2p a share, in an ordinary dividend and £500m or more in a one-off special dividend. A big payout would be politically charged because of the £20bn bailout the bank received at the height of the financial crisis, the Sunday Times noted.Going the other way, like many of its peers, mining giant BHP Billiton is expected to reduce its ,massive $6.6bn (£4.6bn) payout by about 50%. The Sunday Times noted that as well as the plunging prices of commodities, BHP faces billions of dollars in damages after the Samarco dam burst last year.Pearson is expected to write down the value of its overseas divisions to such an extent that it would have slipped into a annual loss had it not been for the sale of the Economist last year, the Sunday Times said. Results are due on Friday.Write-downs will also hit Ladbrokes and William Hill as their annual results are hammered by the first full year of paying the point-of-consumption tax, a 15% levy on online gambling profits and greater regulation of fixed odds betting terminals taxed at 25% and now restricted to four per shop. Ladbrokes will report the first statutory loss in its history, the Sunday Times said, after taking a huge writedown on the value of its ageing betting shops and paying an extra £40m in taxes last year, while Hills is forecast to endure profits plummeting 22%.Gambling software company Playtech is pondering a £250m bid for software developer OpenBet and another for Canada's Amaya. The FTSE 250 company has been under pressure to spend or return its £600m cash pile, the Sunday Times reported, with the potential warchest expanding to £800m if stakes it owns in its rivals are sold.Clothing retailer Joules has hired advisers for a London flotation that could value the business, which is backed by Lloyds' private equity arm LDC, at more than £150m. The Sunday Telegraph said a float was expected in April or May, run by brokers Librium and Peel Hunt.A new, London-listed shell company will be created to buy the football pools from current owner Sportech for roughly £100m. Sportech has granted Hogg preferred bidder status ahead of other suitors, the Sunday Times reported, which had been battling AIM-listed Netplay until late last year.Chancellor George Osborne is plotting a £4bn "tax bombshell" that would hit hundreds of thousands of people saving for their pensions by abolishing the tax-free lump sum, according to a former pensions minister. Currently people can access 25% of their pension pots tax-free in a single lump sum when they reach 55 but Osborne would like to scrap all tax relief on pension contributions and replace it with an Isa-style system, the Sunday Times reported.
More News
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.